Publications

Found 2 results
Filters: Author is X.-W. Zhang  [Clear All Filters]
2012
Y. Guo, Wang, J. - T., Liu, H., Li, M., Yang, T. - L., Zhang, X. - W., Liu, Y. - Z., Tian, Q., and Deng, H. - W., Are bone mineral density loci associated with hip osteoporotic fractures? A validation study on previously reported genome-wide association loci in a Chinese population, vol. 11, pp. 202-210, 2012.
Cooper C, Campion G and Melton LJ, III (1992). Hip fractures in the elderly: a world-wide projection. Osteoporos. Int. 2: 285-289. http://dx.doi.org/10.1007/BF01623184 PMid:1421796 Cummings SR and Melton LJ (2002). Epidemiology and outcomes of osteoporotic fractures. Lancet 359: 1761-1767. http://dx.doi.org/10.1016/S0140-6736(02)08657-9 Deng HW, Mahaney MC, Williams JT, Li J, et al. (2002). Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genet. Epidemiol. 22: 12-25. http://dx.doi.org/10.1002/gepi.1040 PMid:11754470 Gullberg B, Johnell O and Kanis JA (1997). World-wide projections for hip fracture. Osteoporos. Int. 7: 407-413. http://dx.doi.org/10.1007/PL00004148 PMid:9425497 Guo Y, Tan LJ, Lei SF, Yang TL, et al. (2010a). Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis. PLoS Genet. 6: e1000806. http://dx.doi.org/10.1371/journal.pgen.1000806 PMid:20072603    PMCid:2794362 Guo Y, Zhang LS, Yang TL, Tian Q, et al. (2010b). IL21R and PTH may underlie variation of femoral neck bone mineral density as revealed by a genome-wide association study. J. Bone Miner. Res. 25: 1042-1048. PMid:19874204    PMCid:3153368 Hazenberg JG, Taylor D and Lee TC (2007). The role of osteocytes and bone microstructure in preventing osteoporotic fractures. Osteoporos. Int. 18: 1-8. http://dx.doi.org/10.1007/s00198-006-0222-y PMid:16972016 Johnell O, Kanis JA, Oden A, Johansson H, et al. (2005). Predictive value of BMD for hip and other fractures. J. Bone Miner. Res. 20: 1185-1194. http://dx.doi.org/10.1359/JBMR.050304 PMid:15940371 Kanis JA, Oden A, Johnell O, Johansson H, et al. (2007). The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos. Int. 18: 1033-1046. http://dx.doi.org/10.1007/s00198-007-0343-y PMid:17323110 Lau EM, Cooper C, Fung H, Lam D, et al. (1999). Hip fracture in Hong Kong over the last decade - a comparison with the UK. J. Public. Health Med. 21: 249-250. http://dx.doi.org/10.1093/pubmed/21.3.249 Lau EM, Lee JK, Suriwongpaisal P, Saw SM, et al. (2001). The incidence of hip fracture in four Asian countries: the Asian Osteoporosis Study (AOS). Osteoporos. Int. 12: 239-243. http://dx.doi.org/10.1007/s001980170135 PMid:11315243 Marchini J, Howie B, Myers S, McVean G, et al. (2007). A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39: 906-913. http://dx.doi.org/10.1038/ng2088 PMid:17572673 Marshall D, Johnell O and Wedel H (1996). Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312: 1254-1259. http://dx.doi.org/10.1136/bmj.312.7041.1254 PMid:8634613    PMCid:2351094 Melton LJ III (2000). Who has osteoporosis? A conflict between clinical and public health perspectives. J. Bone Miner. Res. 15: 2309-2314. http://dx.doi.org/10.1359/jbmr.2000.15.12.2309 PMid:11127196 Melton LJ III (2003). Adverse outcomes of osteoporotic fractures in the general population. J. Bone Miner. Res. 18: 1139- 1141. http://dx.doi.org/10.1359/jbmr.2003.18.6.1139 PMid:12817771 Price AL, Patterson NJ, Plenge RM, Weinblatt ME, et al. (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38: 904-909. http://dx.doi.org/10.1038/ng1847 PMid:16862161 Richards JB, Rivadeneira F, Inouye M, Pastinen TM, et al. (2008). Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371: 1505-1512. http://dx.doi.org/10.1016/S0140-6736(08)60599-1 Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, et al. (2009). Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat. Genet. 41: 1199-1206. http://dx.doi.org/10.1038/ng.446 PMid:19801982    PMCid:2783489 Siris ES (2006). Patients with hip fracture: what can be improved? Bone 38: S8-12. http://dx.doi.org/10.1016/j.bone.2005.11.014 PMid:16406848 Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, et al. (2008). Multiple genetic loci for bone mineral density and fractures. N. Engl. J. Med. 358: 2355-2365. http://dx.doi.org/10.1056/NEJMoa0801197 PMid:18445777 Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, et al. (2009). New sequence variants associated with bone mineral density. Nat. Genet. 41: 15-17. http://dx.doi.org/10.1038/ng.284 PMid:19079262 Styrkarsdottir U, Halldorsson BV, Gudbjartsson DF, Tang NL, et al. (2010). European bone mineral density loci are also associated with BMD in East-Asian populations. PLoS One 5: e13217. http://dx.doi.org/10.1371/journal.pone.0013217 PMid:20949110    PMCid:2951352
A. - X. Wang, Xu, B., Tong, N., Chen, S. - Q., Yang, Y., Zhang, X. - W., Jiang, H., Liu, N., Liu, J., Hu, X. - N., Sha, G. - Z., and Chen, M., Meta-analysis confirms that a common G/C variant in the pre-miR-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors, vol. 11, pp. 3051-3062, 2012.
Akkiz H, Bayram S, Bekar A, Akgollu E, et al. (2011). No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene 486: 104-109. http://dx.doi.org/10.1016/j.gene.2011.07.006 PMid:21807077   Ambros V (2004). The functions of animal microRNAs. Nature 431: 350-355. http://dx.doi.org/10.1038/nature02871 PMid:15372042   Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5   Bentwich I, Avniel A, Karov Y, Aharonov R, et al. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37: 766-770. http://dx.doi.org/10.1038/ng1590 PMid:15965474   Bhaumik D, Scott GK, Schokrpur S, Patil CK, et al. (2008). Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27: 5643-5647. http://dx.doi.org/10.1038/onc.2008.171 PMid:18504431 PMCid:2811234   Bond GL and Levine AJ (2007). A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans. Oncogene 26: 1317-1323. http://dx.doi.org/10.1038/sj.onc.1210199 PMid:17322917   Catucci I, Yang R, Verderio P, Pizzamiglio S, et al. (2010). Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum. Mutat. 31: E1052-E1057. http://dx.doi.org/10.1002/humu.21141 PMid:19847796   Gao LB, Bai P, Pan XM, Jia J, et al. (2011). The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 125: 571-574. http://dx.doi.org/10.1007/s10549-010-0993-x PMid:20640596   Garcia AI, Cox DG, Barjhoux L, Verny-Pierre C, et al. (2011). The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum Mutat. DOI 10.1002/humu.21539. http://dx.doi.org/10.1002/humu.21539   George GP, Gangwar R, Mandal RK, Sankhwar SN, et al. (2011). Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol. Biol. Rep. 38: 1609-1615. http://dx.doi.org/10.1007/s11033-010-0270-4 PMid:20842445   Guo H, Wang K, Xiong G, Hu H, et al. (2010). A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han. Fam. Cancer 9: 599-603. http://dx.doi.org/10.1007/s10689-010-9370-5 PMid:20680470   Hecht SS (2002). Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 3: 461-469. http://dx.doi.org/10.1016/S1470-2045(02)00815-X   Hirschhorn JN, Lohmueller K, Byrne E and Hirschhorn K (2002). A comprehensive review of genetic association studies. Genet. Med. 4: 45-61. http://dx.doi.org/10.1097/00125817-200203000-00002 PMid:11882781   Hishida A, Matsuo K, Goto Y, Naito M, et al. (2011). Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese. Dig. Dis. Sci. 56: 1131-1137. http://dx.doi.org/10.1007/s10620-010-1376-1 PMid:20721625   Hoffman AE, Zheng T, Yi C, Leaderer D, et al. (2009). microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 69: 5970-5977. http://dx.doi.org/10.1158/0008-5472.CAN-09-0236 PMid:19567675 PMCid:2716085   Hu Z, Liang J, Wang Z, Tian T, et al. (2009). Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 30: 79-84. http://dx.doi.org/10.1002/humu.20837 PMid:18634034   Jazdzewski K, Murray EL, Franssila K, Jarzab B, et al. (2008). Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U. S. A. 105: 7269-7274. http://dx.doi.org/10.1073/pnas.0802682105 PMid:18474871 PMCid:2438239   Ji X, Zhang W, Xie C, Wang B, et al. (2011). Nasopharyngeal carcinoma risk by histologic type in central China: impact of smoking, alcohol and family history. Int. J. Cancer 129: 724-732. http://dx.doi.org/10.1002/ijc.25696 PMid:20878958   Liang PS, Chen TY and Giovannucci E (2009). Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int. J. Cancer 124: 2406-2415. http://dx.doi.org/10.1002/ijc.24191 PMid:19142968   Liu Z, Li G, Wei S, Niu J, et al. (2010). Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116: 4753-4760. http://dx.doi.org/10.1002/cncr.25323 PMid:20549817 PMCid:3030480   Mittal RD, Gangwar R, George GP, Mittal T, et al. (2011). Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in North India. DNA Cell Biol. 30: 401-406. http://dx.doi.org/10.1089/dna.2010.1159 PMid:21345130   Okubo M, Tahara T, Shibata T, Yamashita H, et al. (2010). Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15: 524-531. http://dx.doi.org/10.1111/j.1523-5378.2010.00806.x PMid:21073609   Pallante P, Visone R, Ferracin M, Ferraro A, et al. (2006). MicroRNA deregulation in human thyroid papillary carcinomas. Endocr. Relat. Cancer 13: 497-508. http://dx.doi.org/10.1677/erc.1.01209 PMid:16728577   Pastrello C, Polesel J, Della Puppa L, Viel A, et al. (2010). Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 31: 2124-2126. http://dx.doi.org/10.1093/carcin/bgq184 PMid:20810544   Permuth-Wey J, Thompson RC, Burton NL, Olson JJ, et al. (2011). A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J. Neurooncol. 105: 639-646. http://dx.doi.org/10.1007/s11060-011-0634-1 PMid:21744077   Perry MM, Moschos SA, Williams AE, Shepherd NJ, et al. (2008). Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J. Immunol. 180: 5689-5698. PMid:18390754 PMCid:2639646   Qiu LX, He J, Wang MY, Zhang RX, et al. (2011). The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine 56: 695-698. http://dx.doi.org/10.1016/j.cyto.2011.09.001 PMid:21978540   Reis LO, Pereira TC, Lopes-Cendes I and Ferreira U (2010). MicroRNAs: a new paradigm on molecular urological oncology. Urology 76: 521-527. http://dx.doi.org/10.1016/j.urology.2010.03.012 PMid:20472270   Srivastava K, Srivastava A and Mittal B (2010). Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J. Hum. Genet. 55: 495-499. http://dx.doi.org/10.1038/jhg.2010.54 PMid:20520619   Taganov KD, Boldin MP, Chang KJ and Baltimore D (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103: 12481-12486. http://dx.doi.org/10.1073/pnas.0605298103 PMid:16885212 PMCid:1567904   Tian T, Shu Y, Chen J, Hu Z, et al. (2009). A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol. Biomarkers Prev. 18: 1183-1187. http://dx.doi.org/10.1158/1055-9965.EPI-08-0814 PMid:19293314   Volinia S, Calin GA, Liu CG, Ambs S, et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103: 2257-2261. http://dx.doi.org/10.1073/pnas.0510565103 PMid:16461460 PMCid:1413718   Wang J, Bi J, Liu X, Li K, et al. (2012). Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies. Mol. Biol. Rep. 39: 4571-4579. http://dx.doi.org/10.1007/s11033-011-1247-7 PMid:21947843   Wang X, Tang S, Le SY, Lu R, et al. (2008). Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557. http://dx.doi.org/10.1371/journal.pone.0002557 PMid:18596939 PMCid:2438475   Xu B, Feng NH, Li PC, Tao J, et al. (2010). A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 70: 467-472. http://dx.doi.org/10.1002/pros.21149   Xu T, Zhu Y, Wei QK, Yuan Y, et al. (2008). A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29: 2126-2131. http://dx.doi.org/10.1093/carcin/bgn195 PMid:18711148   Xu W, Xu J, Liu S, Chen B, et al. (2011). Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One 6: e20471. http://dx.doi.org/10.1371/journal.pone.0020471 PMid:21637771 PMCid:3102728   Yue C, Wang M, Ding B, Wang W, et al. (2011). Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. Gynecol. Oncol. 122: 33-37. http://dx.doi.org/10.1016/j.ygyno.2011.03.032 PMid:21529907   Zeng Y, Sun QM, Liu NN, Dong GH, et al. (2010). Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J. Gastroenterol. 16: 3578-3583. http://dx.doi.org/10.3748/wjg.v16.i28.3578 PMid:20653068 PMCid:2909559   Zhou B, Wang K, Wang Y, Xi M, et al. (2011). Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol. Carcinog. 50: 499-505. http://dx.doi.org/10.1002/mc.20740 PMid:21319225   Zhou J, Lv R, Song X, Li D, et al. (2012). Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol. 31: 524-530. http://dx.doi.org/10.1089/dna.2011.1340 PMid:21861697